NBRVF
NABRIVA THERAPEUTICS NEW by Nabriva Therapeutics plc (NBRVF)
$00
About NABRIVA THERAPEUTICS NEW by Nabriva Therapeutics plc (NBRVF)
Nabriva Therapeutics Plc is a biopharmaceutical company, which engages in the commercialization and development of novel anti-infective agents to treat infections. The company was founded in October 2005 and is headquartered in Dublin, Ireland.
Details
Daily high
--
Daily low
--
Price at open
--
52 Week High
$0.01
52 Week Low
$0.00
Market cap
300
Dividend yield
0.00%
Volume
50
Avg. volume
105
P/E ratio
--
NABRIVA THERAPEUTICS NEW by Nabriva Therapeutics plc News
Details
Daily high
--
Daily low
--
Price at open
--
52 Week High
$0.01
52 Week Low
$0.00
Market cap
300
Dividend yield
0.00%
Volume
50
Avg. volume
105
P/E ratio
--